Printer Friendly

GULL LABORATORIES AND BAXTER INTERNATIONAL ENTER MANUFACTURING/DISTRIBUTION AGREEMENT

 GULL LABORATORIES AND BAXTER INTERNATIONAL
 ENTER MANUFACTURING/DISTRIBUTION AGREEMENT
 SALT LAKE CITY, March 2 /PRNewswire/ -- Gull Laboratories Inc. (NASDAQ: GULL), a Salt Lake City-based manufacturer and marketer of diagnostic test kits has entered into an agreement to manufacture medical diagnostic test kits for distribution by Bartels Diagnostics, a division of Baxter Diagnostics Inc.
 Gull Laboratories will manufacture a total of 17 different diagnostic tests for infectious diseases, including both indirect fluorescence (IFA) and enzyme-linked immunosorbent assay (ELISA) tests. The tests will complement Baxter Bartels Diagnostics proprietary lines of diagnostic products.
 The Gull-manufactured tests will be distributed through Baxter's Scientific Products division and other Baxter distributors worldwide. Commenting on the agreement, Gull C.E.O., Milton Adair, said, "We entered this year with a goal to significantly strengthen the domestic distribution of our diagnostic product line. The addition of Baxter's sizeable sales forces within Scientific Products and Bartels Diagnostics marks a major step towards the accomplishment of that goal. This agreement provides Gull-manufactured product lines with access to markets previously unavailable, such as end-users who acquire products through national purchasing contracts."
 Bartels Diagnostics introduced the PRIMA System(TM) in late 1991 as the first clinical laboratory system with the capability to provide both enzyme immunosorbent assays (EIA) and enzyme probe assays (EPA) in a standard microtitre format on a single instrument. Gull Laboratories' products allow Bartels to augment proprietary enzyme probe assays (EPA) and enzyme immunosorbent assays (EIA), resulting in a full complement of antibody, antigen and toxin targeted tests to meet the needs of clinical laboratories.
 Founded in 1974, Gull Laboratories develops, manufactures and markets high-quality diagnostic test kits for the detection of infectious diseases. The company markets these products for use in hospitals and clinical laboratories around the world.
 Baxter International is the leading worldwide manufacturer and marketer of health-care products, systems and services. It offers 120,000 products to healthcare providers in 100 countries.
 -0- 3/2/92
 /CONTACT: Peter Van Duser of Gull Laboratories, 801-263-3524; or John Metzger of Metzger Associates, 303-786-7000, for Gull Laboratories/
 (GULL) CO: Gull Laboratories Inc.; Baxter International Inc. ST: Utah IN: MTC HEA SU:


TS -- DV002 -- 3857 03/02/92 10:31 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 2, 1992
Words:361
Previous Article:ANOTHER FIRST FOR GAMMA BIOLOGICALS; COMPANY RECEIVES FIRST EVER LICENSE FOR MONOCLONAL COOMBS REAGENTS
Next Article:MAPI ANALYSIS CONCLUDES THAT CANADIAN HEALTH CARE SYSTEM IS WRONG APPROACH FOR U.S. REFORM, OUTLINES BETTER ALTERNATIVES
Topics:


Related Articles
GULL LABS NAMES NEW PRODUCT DEVELOPMENT DIRECTOR
GULL LABS REPORTS 1991 SALES OF $6.9 MILLION
GULL LABS SETS SHAREHOLDERS' MEETING
GULL LABORATORIES FORMS NEW MANUFACTURING, DISTRIBUTION UNIT
GULL LABORATORIES REPORTS CLIMB IN FIRST HALF SALES AND EARNINGS
GULL LABS SETS EUROPEAN MEDICAL DIAGNOSTICS CONFERENCE
GULL LABORATORIES NAMES MILTON ADAIR PRESIDENT
Gull Labs and Shield Diagnostics Announce Distribution Agreement
American Biogenetic Sciences, Inc. and Gull Laboratories, Inc. Announce Strategic Alliance on Product Manufacture and Distribution
Gull Labs Awarded Quest Diagnostics Test Kit Contract

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters